Bluesight Acquires Protenus to Enhance Healthcare Compliance
Deal News | Jan 09, 2025 | Arthur Ventures LLC
Bluesight, a leader in inventory management and compliance solutions for healthcare, has acquired Protenus, a pioneering provider of healthcare compliance analytics. The acquisition aims to fortify Bluesight's drug diversion platform and integrate Protenus's advanced patient privacy monitoring capabilities. This strategic move enhances Bluesight's offerings by merging its operational intelligence with Protenus's expertise in compliance and risk management. Both companies are excited about the synergy, emphasizing the shared mission to provide innovative compliance solutions that enhance patient safety and operational efficiency. Financial and legal advisories for the transaction were provided by Baird, Kirkland & Ellis LLP, and DLA Piper LLP.
Sectors
- Healthcare Technology
- Mergers & Acquisitions
Geography
- United States – Both Bluesight and Protenus operate extensively within the United States, and the acquisition is likely to impact healthcare organizations across the country.
- Canada – Bluesight's solutions are used in Canadian hospitals, indicating the geographic reach of their operations and potential impact of the acquisition.
Industry
- Healthcare Technology – The article discusses the acquisition of Protenus, a healthcare compliance analytics provider, by Bluesight, a company offering inventory management and compliance solutions for health systems and hospital pharmacies.
- Mergers & Acquisitions – The article details a strategic acquisition aimed at consolidating resources and expertise across healthcare technology firms to enhance compliance and operational efficiency.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Bluesight | Acquiring Company | Company | Provider of inventory management, procurement, and compliance solutions for health systems and hospital pharmacies. |
| Protenus | Target Company | Company | Provider of healthcare compliance analytics platform leveraging AI to reduce operational risks in healthcare. |
| Arthur Ventures LLC | Private Equity Firm | Company | Private equity firm involved with Bluesight. |
| Baird | Financial Advisor | Company | Provided financial advisory services to Protenus in the acquisition. |
| Kirkland & Ellis LLP | Legal Advisor | Company | Served as legal counsel for Thoma Bravo & Bluesight. |
| DLA Piper LLP | Legal Advisor | Company | Served as legal counsel for Protenus. |
| Thoma Bravo | Selling Company/Vendor | Company | Involved as vendor possibly holding stake in Protenus. |